Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Affymetrix, Inc.    AFFX   US00826T1088

AFFYMETRIX, INC. (AFFX)

20
Delayed Quote. Delayed Nasdaq - 08/29 04:00:02 pm
8.67 USD   +2.24%
3d ago AFFYMETRIX : Assigned Patent
5d ago AFFYMETRIX : Patent Issued for Methods for Genotyping Selected Polymorphism
6d ago AFFYMETRIX : Assigned Patent
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Affymetrix, Inc. : Affymetrix to Host Conference Call on May 3, 2012 to Announce First Quarter 2012 Operating Results

04/17/2012 | 04:20pm US/Eastern
Recommend:
0

Affymetrix, Inc. (NASDAQ: AFFX) today announced that its first quarter 2012 operating results will be reported after market close on Thursday May 3, 2012. The company will also hold a conference call on the same day at 5:00pm ET.

A live webcast can be accessed by visiting the investor relations section of the company's website at www.affymetrix.com. Alternatively, investors and other interested parties may listen to the live conference call by dialing 877-407-8291 (domestic) or 201-689-8345 (international).

A replay of this call will be available from 5:00pm PT on May 3, 2012 until 8:00pm PT on May 10, 2012 at the following numbers: 877-660-6853 (domestic), 201-612-7415 (international). The conference identification number for the replay is 392482. An archived webcast of the conference call will be available under the investor relations section of the company's website at www.affymetrix.com.

About Affymetrix

Affymetrix technology is used by the world's top pharmaceutical, diagnostic, and biotechnology companies, as well as leading academic, government, and nonprofit research institutes. More than 2,000 systems have been shipped globally and approximately 25,000 peer-reviewed papers have been published using the technology.

Affymetrix is headquartered in Santa Clara, Calif., and has manufacturing facilities in Santa Clara, Cleveland, Ohio, and Singapore. The company has about 900 employees worldwide and maintains sales and distribution operations across Europe, Asia, and Latin America. For more information about Affymetrix, please visit www.affymetrix.com.

Affymetrix, Inc.
Investor:
Doug Farrell, 408-731-5285
Vice President, Investor Relations


© Business Wire 2012
Recommend :
0
React to this article
Latest news on AFFYMETRIX, INC.
3d ago AFFYMETRIX : Assigned Patent
5d ago AFFYMETRIX : Patent Issued for Methods for Genotyping Selected Polymorphism
6d ago AFFYMETRIX : Assigned Patent
08/22 AFFYMETRIX : Presolicitation Notice - Maintenance Agreement - GCS3000 Assurance
08/13 AFFYMETRIX : Patent Issued for System and Method for Processing Large Number of ..
08/13 AFFYMETRIX : SNP Arrays and Reagent Kit Sought by Health and Human Services
08/12 AFFYMETRIX : Assigned Patent
08/08 AFFYMETRIX : Gene Chip Array Sought by Health and Human Services
08/08 AFFYMETRIX : Presolicitation Notice - Purchase from Affymetrix - ARRAY, GENOME-W..
08/06 AFFYMETRIX : Patent Issued for DNA Ligation on RNA Template
Advertisement
Chart
Duration : Period :
Affymetrix, Inc. Technical Analysis Chart | AFFX | US00826T1088 | 4-Traders
Income Statement Evolution
Affymetrix, Inc. : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF